First Clinical Trial In Bay Area To Test Effect Of HIV Vaccine; SF Department Of Public Health And UCSF Recruiting Study Volunteers

The first clinical trial in the Bay Area to test the effectiveness of an AIDS vaccine was launched this week through a joint project of the San Francisco Department of Public Health and the University of California San Francisco. Known as a Phase III trial, the DPH/UCSF study will focus on the ability of the test vaccine to protect the body against HIV infection. It is part of a three-year, multi-site clinical research effort that is the first in the U.S. to look specifically at this aspect of a test vaccine.

The test vaccine is produced through genetic engineering techniques, so it is a synthetic product and does not contain any live virus. It cannot cause HIV infection.

The test vaccine product, named AIDSVAX, was developed by VaxGen, a biotech company based in Brisbane, Calif. The overall trial is being carried out at more than 50 locations throughout North America with the goal of enrolling 5,000 participants.

The DPH/UCSF team hopes to enroll 300 study volunteers. Study co-directors are Susan Buchbinder, M.D., chief of the HIV Research Section at DPH, and James Kahn, M.D., associate professor in the UCSF Positive Health Program at San Francisco General Hospital Medical Center.

The test vaccine is designed to train the immune system to develop a defense mechanism against the outer covering of HIV so the virus fails to spread throughout the body. It is not known if this approach will be effective in protecting the body against infection. Learning the answer is the overall objective of the Phase III trial.

In order to take part, volunteers must be adults who currently are HIV-negative and at risk for HIV infection through sexual exposure. All volunteers will receive extensive counseling that will focus on reducing the chance of becoming exposed to HIV.

The trial is a "double-blind" study with some participants receiving the test vaccine and some participants receiving a placebo, an inactive substance used as a comparison. N

Contact: Corinna Kaarlela
University of California - San Francisco

Page: 1 2 3 4

Related medicine news :

1. First head-to-head study to compare lidoderm patch and Celebrex in treating pain
2. First UK cases of previously rare disease reported in gay men
3. First mouse model for multiple system atrophy points to new treatment targets for brain diseases
4. Mayo Clinic researchers create obedient virus; First step to use measles virus against cancer
5. First US kidney cancer vaccine trial underway at Columbia
6. First new treatment for alcoholism in ten years, now available Campral(R) (acamprosate calcium)
7. First blood test to diagnose paralyzing, blinding disease
8. First US SARS vaccine trial opens at NIH
9. First-ever safety study of medical cannabis use in Canada launched
10. First solid evidence that the study of music promotes intellectual development
11. First medical test on CD gets good results

Post Your Comments:

(Date:4/1/2020)... HERNDON, Va. (PRWEB) , ... April 01, 2020 , ... ... collection accounts, and forms for teams adjusting to new needs based on COVID-19. , ... a hurdle for groups of all types. , Zerion will extend support by offering ...
(Date:3/28/2020)... ... March 27, 2020 , ... With social ... cases grow by the day, people of all ages are challenged to find ... with social interactions in the best of times—the physical distance mandated to prevent ...
(Date:3/28/2020)... , ... March 28, 2020 , ... ... Physical Therapy Services (EPPTS), a physical therapist-owned rehabilitation company since 1985 specializing in ... Paso, TX. , “Since we started more than 30 years ago, we have ...
(Date:3/22/2020)... ... March 21, 2020 , ... The modular construction ... Builders Association (MHBA), have been working with state and federal officials on ways ... for greater use of modular construction to address the nation’s affordable housing crisis ...
(Date:3/20/2020)... ... March 20, 2020 , ... My heart goes out ... from COVID-19. Having also lost a loved one recently through similar circumstances - underlying ... few days, I have felt a gamut of negative emotions just like many have: ...
Breaking Medicine News(10 mins):
(Date:3/28/2020)... ... March 27, 2020 , ... Based on ... named Gary Gallant as its permanent CIO. In this executive leadership team role, ... Isagenix can provide a smooth shopping experience for customers and digital tools that ...
(Date:3/27/2020)... ... March 27, 2020 , ... Shady Grove Fertility (SGF) —home ... board certified fertility specialists through virtual physician consults , thereby minimizing interruptions in ... SGF over its 29 year history has always been to improve access to care. ...
(Date:3/20/2020)... N.J. (PRWEB) , ... March 20, 2020 , ... ... of the Suntuity Group of companies with its US headquarters in New Jersey, ... services and support to organizations affected and present in the local communities across ...
Breaking Medicine Technology:
Cached News: